BioBefore joining Blackstone, Mr. Shepherd worked for the prior seven years as a Managing Director with DRI Capital, a life sciences private equity firm dedicated to the acquisition of pharmaceutical royalties through its managed funds Drug Royalty I, II and III. From 2010-2017, Mr. Shepherd was a member of the DRI Investment Committee and leadership team, and he also served on the board of DRI’s third fund, Drug Roya ....
Education